Related Experiment Video
Updated: Jun 19, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
[Endothelial dysfunction in patients with combined coronary heart disease and chronic obstructive pulmonary disease]
Insights
Chronic coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD) worsen each other, increasing disease severity. The reactive hyperemia test is the most effective method for diagnosing endothelial dysfunction in these patients.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Biology
Background:
- Endothelial dysfunction is a key factor in cardiovascular and respiratory diseases.
- Chronic coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD) often coexist, potentially exacerbating each other.
- Accurate assessment of endothelial function is crucial for managing patients with combined CHD and COPD.
Purpose of the Study:
- To evaluate endothelial dysfunction in patients with CHD and COPD.
- To compare endothelial function in patients with CHD alone, COPD alone, and combined CHD and COPD.
- To identify the most informative diagnostic method for endothelial dysfunction in this patient population.
Main Methods:
- Instrumental and laboratory methods were used to assess endothelial function.
- Nitrogen oxide (NO) metabolite levels were measured.
- Reactive hyperemia testing was performed.
- A comparative analysis was conducted across three patient groups: CHD with COPD, stable angina alone, and COPD alone.
Main Results:
- Combined CHD and COPD potentiate pathological processes, leading to disease aggravation.
- Plasma nitrogen oxide metabolite levels did not accurately reflect nitric oxide availability in patients with cardiovascular issues or COPD.
- The reactive hyperemia test demonstrated significant informativeness in assessing endothelial function.
Conclusions:
- Endothelial dysfunction is significantly impacted by the co-occurrence of CHD and COPD.
- Standard blood markers for nitrogen oxide metabolites are insufficient for evaluating endothelial function in these patients.
- The reactive hyperemia test is the recommended method for assessing endothelial function in patients with CHD and COPD.
Abstract:
The aim of this work was to evaluate functional incompetence of endothelium in patients with chronic coronary heart disease (CHD, stable angina) combined with chronic obstructive pulmonary disease and to choose the most informative method for the diagnosis of endothelial dysfunction. A total of 103 patients aged 36-66 (mean 57.2 +/- 7.6) years were examined. Group 1 comprised 38 patients with CHD and concomitant chronic obstructive pulmonary disease (COPD). Group 2 included 36 patients with stable angina alone, group 3 consisted of 29 patients with COPD without CHD. Attention is focused on the characteristic of endothelial function by instrumental and laboratory methods. Comparative analysis of the severity of endothelial dysfunction in patients of the three groups revealed different mechanisms of plasma nitrogen oxide dynamics in patients with CHD and/or COPD. CHD and COPD caused mutual aggravation (potentiation) of pathological reactions leading to the development of the disease. Blood levels of nitrogen oxide metabolites in patients with cardiovascular problems or with COPD alone did not reflect the actual amount of "vasodilatory" NO. Reactive hyperemia test is believed to be the most informative method for the assessment of endothelial function in patients with CHD and COPD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
